XVIPFStock
Verdicts genuinely change. Free email alert the moment XVIPF's does — no target price to set, unlike "Alert" above.
Whether this company clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
Trade setup
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
XVIPF is currently considered halal (Sharia-compliant), per In-house ratio engine. See the full ratio breakdown and business-activity screen below for the reasoning.
This sits among 451 compliant Healthcare stocks we track. See compliant Healthcare stocks →
🕌 In-house Compliance Research
Computed from published company financials, balance sheet as of 2025-12-31. These ratios come from the issuer's own published statements rather than structured SEC data.
Business activity: cleared (no excluded categories detected)
AAOIFI Pass 3 of 3 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 1.39% | 30.00% | Pass |
| Interest-bearing investments | 3.25% | 30.00% | Pass |
| Non-permissible income | 0.97% | 5.00% | Pass |
Usmani Pass 4 of 4 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 10.51% | 33.00% | Pass |
| Interest-bearing investments | 12.30% | 33.00% | Pass |
| Non-liquid assets | 83.43% | at least 20.00% | Pass |
| Non-permissible income | 0.97% | 5.00% | Pass |
MSCI Pass 4 of 4 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 5.25% | 33.33% | Pass |
| Cash + interest-bearing securities | 12.30% | 33.33% | Pass |
| Accounts receivable | 16.57% | 33.33% | Pass |
| Non-permissible income | 0.97% | 5.00% | Pass |
FTSE Pass 4 of 4 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 5.25% | 33.33% | Pass |
| Cash + interest-bearing securities | 12.30% | 33.33% | Pass |
| Accounts receivable | 16.57% | 50.00% | Pass |
| Non-permissible income | 0.97% | 5.00% | Pass |
Dow Jones Islamic Market Pass 4 of 4 ratios pass
Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 1.09% | 33.00% | Pass |
| Cash + interest-bearing securities | 2.56% | 33.00% | Pass |
| Accounts receivable | 0.89% | 33.00% | Pass |
| Non-permissible income | 0.97% | 5.00% | Pass |
S&P Shariah Pass 4 of 4 ratios pass
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 1.00% | 33.00% | Pass |
| Cash + interest-bearing securities | 2.34% | 49.00% | Pass |
| Accounts receivable | 0.81% | 49.00% | Pass |
| Non-permissible income | 0.97% | 5.00% | Pass |
MSCI M-Series Pass 4 of 4 ratios pass
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 1.00% | 33.33% | Pass |
| Cash + interest-bearing securities | 2.34% | 33.33% | Pass |
| Accounts receivable | 3.15% | 49.00% | Pass |
| Non-permissible income | 0.97% | 5.00% | Pass |
Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.
How close is it to flipping?
Every current reading against its own line, closest first. A verdict is only as durable as that distance.
The numbers the ratios are built from
Read from XVIPF's own filings. Every percentage on this page is one of these lines divided by another, so the inputs are shown rather than asserted.
| Line | Figure | As reported | Read from |
|---|---|---|---|
| RevenueTotal revenue for the period | $88.2M | 2025-12-31 | yahoo:annualTotalRevenue |
| Interest-bearing debtShort and long-term borrowings | $13.5M | 2025-12-31 | yahoo:annualTotalDebt |
| Cash and interest-bearing securitiesCash, equivalents and marketable securities | $31.7M | 2025-12-31 | yahoo:annualCashCashEquivalentsAndShortTermInvestments |
| Total assetsBalance sheet total | $257.8M | 2025-12-31 | yahoo:annualTotalAssets |
| Market capDenominator for AAOIFI | $974.9M | live quote | price x shares |
| 36-month average market capDenominator for S&P Shariah and MSCI M-Series | $953.1M | 756 trading days | closes x shares |
| 24-month average market capDenominator for Dow Jones Islamic Market | $931.0M | 504 trading days | closes x shares |
| Non-permissible revenueInterest and excluded income | $855.3K | 2025-12-31 | yahoo:annualInterestIncome |
Two dates, not one: a balance-sheet line and an income-statement line cover different windows by design, so each figure carries its own.
What changed, and when
Verdict history for XVIPF. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.
- 2026-09-07 No change recorded No verdict change for XVIPF has been recorded since tracking began. The scan ledger records that the compliance detectors ran, not which symbols each pass covered.
ℹ️ no compliance scan has run for 4 days - this is not a reading of today
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
This fund prices once a day, so its bars carry no intraday high or low — floor-trader pivots are not defined for it.
Price Forecast
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Technical Summary
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Every indicator, and what it reads
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 8.80 | BUY |
| Stochastic %K (14) | 0.00 | BUY |
| CCI (20) | -66.67 | NEUTRAL |
| Williams %R (14) | -100.00 | BUY |
| MACD (12,26,9) | 0.22 | BUY |
| ROC (10) | -0.55 | SELL |
| Momentum (10) | -0.12 | SELL |
| EMA (10) | 21.72 | SELL |
| SMA (10) | 21.68 | SELL |
| EMA (20) | 22.09 | SELL |
| SMA (20) | 21.74 | SELL |
| EMA (30) | 22.71 | SELL |
| SMA (30) | 22.08 | SELL |
| EMA (50) | 23.78 | SELL |
| SMA (50) | 24.94 | SELL |
| EMA (100) | 24.80 | SELL |
| SMA (100) | 26.21 | SELL |
| EMA (200) | 23.84 | SELL |
| SMA (200) | 24.82 | SELL |
About XVIPF
Healthcare · Medical Devices
Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates through Thoracic; Abdominal; Services; and other segments. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours; Liver Assist that provides clinicians a choice of perfusion protocols whether hypothermic, normothermic, sub-normothermic, or a combination; XVIVO System (XPS), a comprehensive ex vivo lung perfusion (EVLP) platform that offers an overview of the entire process; and STEEN Solution, a buffered extracellular solution intended for the assessment of isolated lungs after removal from the donor in preparation for eventual transplantation into a recipient. It also provides Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XPS Disposable Lung Kit that contains all the necessary devices and tubing to run a normothermic EVLP procedure on the XPS; XVIVO Organ Chamber, a sterile single-use container intended to be used as a temporary receptacle for isolated donor lungs; and XVIVO Lung Cannula Set, a sterile single-use set that connects isolated donor lungs to an extracorporeal perfusion system for ex-vivo assessment. In addition, the company offers Kidney Assist that provides clinicians with a choice of perfusion protocols from hypothermic to normothermic perfusion; and Gisto, an integrated system for organ transportation. It operates in Sweden; The Netherlands; The United States; Italy; North and South America; Asia/Pacific and Oceania; and internationally. Xvivo Perfusion AB (publ) was incorporated in 1998 and is headquartered in Mölndal, Sweden.
Background via Yahoo Finance — informational, not part of the verdict.
SMC — Top Down
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
Peer Movement
How the rest of the sector moved over the same window. Context for a price move, never a cause of one.
Peer movement computing — it will appear here on its own.
Before you act on this
The questions worth asking about any verdict on this page, answered plainly.
Is this a fatwa?
No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.
Why can the standards disagree?
Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.
How often is this re-screened?
Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.
Do I need to purify dividends?
If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from — the purification calculator finishes it, showing the filing figures behind the ratio and both the proportional and the AAOIFI per-share convention.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Compare with
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Insider Activity (90d)
Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.
NO DATA 0 buys · 0 sells
COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE
The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.
NEUTRAL report date 2026-11-03 · Asset managers net 928584 (+5135)
AI Summary
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.